| Obesity |
1 |
1 |
| Metabolism |
0 |
0.63 |
| Obesity in Children |
0 |
0.63 |
| Metabolic Syndrome |
0 |
0.51 |
| LDL Cholesterol |
0 |
0.49 |
| Cardiovascular Risk Management |
0 |
0.42 |
| Lipids Management |
0 |
0.34 |
| Biliary Disease |
0 |
0.29 |
| Adolescent Medicine |
0 |
0.27 |
| Diet |
0 |
0.99 |
| Plantar |
0 |
0.27 |
| Non-Alcoholic Fatty Liver Disease |
0 |
0.25 |
| Corns |
0 |
0.18 |
| Hypertension |
0 |
0.18 |
| Lipoproteins |
0 |
0.18 |
| Young Adult |
0 |
0.18 |
| Fatty Liver |
0 |
0.13 |
| Liver Disease |
0 |
0.13 |
| Toxicology |
0 |
0.12 |
| Type 2 Diabetes Mellitus |
0 |
0.12 |
| Weight Management |
0 |
0.12 |
| Myocardial Infarction (MI) |
0 |
0.1 |
| Cadaver |
0 |
0.09 |
| Cancer |
0 |
0.09 |
| Cardiovascular disease |
0 |
0.09 |
| Child |
0 |
0.09 |
| Endocrinology |
0 |
0.09 |
| Fatty Acids |
0 |
0.09 |
| Food and Drug Administration (FDA) |
0 |
0.09 |
| Genetics |
0 |
0.09 |
| Genomic Medicine |
0 |
0.09 |
| Grant |
0 |
0.09 |
| Heart |
0 |
0.09 |
| Hospital |
0 |
0.09 |
| Hypothalamus |
0 |
0.09 |
| Imbalance |
0 |
0.09 |
| Infarction |
0 |
0.09 |
| Liver |
0 |
0.09 |
| Massachusetts |
0 |
0.09 |
| Weight Gain |
0 |
0.09 |
| Cerebrovascular Accident |
0 |
0.06 |